
### [MONDO:0015624](http://purl.obolibrary.org/obo/MONDO_0015624)
**Label:** Diazoxide-sensitive diffuse hyperinsulinism

**Subclasses:** [MONDO:0009278](http://purl.obolibrary.org/obo/MONDO_0009278) (hyperinsulinism due to short chain 3-hydroxylacyl-CoA dehydrogenase deficiency), 

**Corr. equiv. classes:** [Orphanet:71212](http://www.orpha.net/ORDO/Orphanet_71212), [OMIM:609975](http://purl.obolibrary.org/obo/OMIM_609975), [OMIM:231530](http://purl.obolibrary.org/obo/OMIM_231530), 

**Class expressions from DL-Learner:**

- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0500015](http://purl.obolibrary.org/obo/HP_0500015) (Abnormal cardiac test) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0500014](http://purl.obolibrary.org/obo/HP_0500014) (Abnormal test result) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0100950](http://purl.obolibrary.org/obo/HP_0100950) (Decreased activity of 3-hydroxyacyl-CoA dehydrogenase) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0040300](http://purl.obolibrary.org/obo/HP_0040300) (Abnormal circulating free fatty acid level) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0031547](http://purl.obolibrary.org/obo/HP_0031547) (Abnormal QT interval) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0031137](http://purl.obolibrary.org/obo/HP_0031137) (Storage in hepatocytes) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0030956](http://purl.obolibrary.org/obo/HP_0030956) (Abnormality of cardiovascular system electrophysiology) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0030796](http://purl.obolibrary.org/obo/HP_0030796) (Increased C-peptide level) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0030794](http://purl.obolibrary.org/obo/HP_0030794) (Abnormal C-peptide level) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0030781](http://purl.obolibrary.org/obo/HP_0030781) (Increased circulating free fatty acid level) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0025155](http://purl.obolibrary.org/obo/HP_0025155) (Abnormality of hepatobiliary system physiology) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.67%
- [HP:0008283](http://purl.obolibrary.org/obo/HP_0008283) (Fasting hyperinsulinemia) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.67%


